Journal article
The reality of using primaquine.
- Abstract:
-
BACKGROUND: Primaquine is currently the only medication used for radical cure of Plasmodium vivax infection. Unfortunately, its use is not without risk. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency have an increased susceptibility to haemolysis when given primaquine. This potentially fatal clinical syndrome can be avoided if patients are tested for G6PD deficiency and adequately informed before being treated. CASE PRESENTATION: A 35-year old male presented to our clinic ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Wellcome Trust
More from this funder
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- Malaria Journal Journal website
- Volume:
- 9
- Issue:
- 1
- Article number:
- 376
- Publication date:
- 2010-01-01
- DOI:
- EISSN:
-
1475-2875
- ISSN:
-
1475-2875
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:110179
- UUID:
-
uuid:05ab2cab-7fa2-43c5-91c9-e36df2123f42
- Local pid:
- pubs:110179
- Source identifiers:
-
110179
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- Burgoine et al
- Copyright date:
- 2010
- Notes:
- © 2010 Burgoine et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record